nach oben

Erschienen in:

10.07.2021 | Original Article

Factors associated with sleep disturbances in women undergoing treatment for early-stage breast cancer

verfasst von: Susan Grayson, Susan Sereika, Caroline Harpel, Emilia Diego, Jennifer G. Steiman, Priscilla F. McAuliffe, Susan Wesmiller

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to examine factors associated with sleep disturbance in women receiving adjuvant therapy for breast cancer.

Methods

This study employed a cross-sectional design using data collected at 3 months post-surgery from an ongoing longitudinal parent study. Participant data were divided into adjuvant treatment groups (chemotherapy, radiation, and aromatase inhibitors) and no adjuvant treatment groups. Symptoms were measured using patient self-report measures. Analysis of variance was used to assess between adjuvant treatment group differences in sleep disturbance. Regression analysis was performed to assess the relationship between sleep disturbance and other symptoms within adjuvant treatment groups.

Results

The sample included 156 women diagnosed with early-stage breast cancer. There were significant differences in levels of reported sleep disturbance between treatment groups (p = 0.049), with significantly higher levels of sleep disturbances in those receiving radiation compared to those receiving no adjuvant treatment (p = 0.038) and in those receiving chemotherapy and those receiving no adjuvant treatment (p = 0.027). Increased sleep disturbance was found to be a significant predictor for increased pain severity, nausea severity, anxiety, depressive symptoms, fatigue, decreased physical function, and decreased ability to participate in social roles and activities. Co-occurring symptoms with sleep disturbance differed between adjuvant treatment groups. Sleep disturbance was also associated with younger age (p = 0.008).

Conclusions

Patients undergoing chemotherapy or radiation for breast cancer report higher levels of sleep disturbance than those not receiving adjuvant therapy. Sleep disturbance is associated with other symptoms experienced by patients with cancer and thus requires continual assessment and future research into effective interventions.

Whisenant M, Wong B, Mitchell SA, Beck SL, Mooney K (2017) Distinct trajectories of fatigue and sleep disturbance in women receiving chemotherapy for breast cancer. Oncol Nurs Forum 44(6):739–750. https://doi.org/10.1188/17.ONF.739-750CrossRefPubMedPubMedCentral

Dhruva A, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, Dunn LB, Swift PS, Wara W, Miaskowski C (2012) A longitudinal study of measures of objective and subjective sleep disturbance in patients with breast cancer before, during, and after radiation therapy. J Pain Symptom Manage 44(2):215–228. https://doi.org/10.1016/j.jpainsymman.2011.08.010CrossRefPubMedPubMedCentral

Leysen L, Lahousse A, Nijs J, Adriaenssens N, Mairesse O, Ivakhnov S, Bilterys T, Van Looveren E, Pas R, Beckwée D (2019) Prevalence and risk factors of sleep disturbances in breast cancer survivors: systematic review and meta-analyses. Support Care Cancer 27(12):4401–4433. https://doi.org/10.1007/s00520-019-04936-5CrossRefPubMed

Albusoul RM, Berger AM, Gay CL, Janson SL, Lee KA (2017) Symptom clusters change over time in women receiving adjuvant chemotherapy for breast cancer. J Pain Symptom Manage 53(5):880–886. https://doi.org/10.1016/j.jpainsymman.2016.12.332CrossRefPubMedPubMedCentral

Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed

Wang JP, Lu SF, Guo LN, Ren CG, Zhang ZW (2019) Poor preoperative sleep quality is a risk factor for severe postoperative pain after breast cancer surgery: a prospective cohort study. Medicine (Baltimore) 98(44):e17708. https://doi.org/10.1097/MD.0000000000017708CrossRef

Van Onselen C, Aouizerat BE, Dunn LB, Paul SM, West C, Hamolsky D, Lee K, Melisko M, Neuhaus J, Miaskowski C (2013) Differences in sleep disturbance, fatigue and energy levels between women with and without breast pain prior to breast cancer surgery. Breast 22(3):273–276. https://doi.org/10.1016/j.breast.2012.07.007CrossRefPubMed

Peoples AR, Pigeon WR, Li D, Garland SN, Perlis ML, Inglis JE, Vinciguerra V, Anderson T, Evans LS, Wade JL, Ossip DJ, Morrow GR, Wolf JR (2021) Association between pretreatment sleep disturbance and radiation therapy-induced pain in 573 women with breast cancer. J Pain Symptom Manage 61(2):254–261. https://doi.org/10.1016/j.jpainsymman.2020.07.041CrossRefPubMed

Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S (2012) Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun 26(5):706–713. https://doi.org/10.1016/j.bbi.2012.02.001CrossRefPubMedPubMedCentral

10.

Mark S, Cataldo J, Dhruva A, Paul SM, Chen LM, Hammer MJ, Levine JD, Wright F, Melisko M, Lee K, Conley YP, Miaskowski C (2017) Modifiable and non-modifiable characteristics associated with sleep disturbance in oncology outpatients during chemotherapy. Support Care Cancer 25(8):2485–2494. https://doi.org/10.1007/s00520-017-3655-2CrossRefPubMedPubMedCentral

11.

Steel JL, Terhorst L, Collins KP, Geller DA, Vodovotz Y, Kim J, Krane A, Antoni M, Marsh JW, Burke LE, Butterfield LH, Penedo FJ, Buysse DJ, Tsung A (2018) Prospective analyses of cytokine mediation of sleep and survival in the context of advanced cancer. Psychosom Med 80(5):483–491. https://doi.org/10.1097/PSY.0000000000000579CrossRefPubMedPubMedCentral

12.

Jung D, Lee KM, Kim WH, Lee JY, Kim TY, Im SA, Lee KH, Spiegel D, Hahm BJ (2016) Longitudinal association of poor sleep quality with chemotherapy-induced nausea and vomiting in patients with breast cancer. Psychosom Med 78(8):959–965. https://doi.org/10.1097/PSY.0000000000000372CrossRefPubMed

13.

Peoples AR, Roscoe JA, Block RC, Heckler CE, Ryan JL, Mustian KM, Janelsins MC, Peppone LJ, Moore DF Jr, Coles C, Hoelzer KL, Morrow GR, Dozier AM (2017) Nausea and disturbed sleep as predictors of cancer-related fatigue in breast cancer patients: a multicenter NCORP study. Support Care Cancer 25(4):1271–1278. https://doi.org/10.1007/s00520-016-3520-8CrossRefPubMed

14.

Tejada M, Viele C, Kober KM, Cooper BA, Paul SM, Dunn LB, Hammer MJ, Wright F, Conley YP, Levine JD, Miaskowski C (2019) Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms. Sleep 42(10):zsz151. https://doi.org/10.1093/sleep/zsz151CrossRefPubMedPubMedCentral

15.

Berger AM, Kupzyk KA, Djalilova DM, Cowan KH (2019) Breast Cancer Collaborative Registry informs understanding of factors predicting sleep quality. Support Care Cancer 27(4):1365–1373. https://doi.org/10.1007/s00520-018-4417-5CrossRefPubMed

16.

Berger AM, Matthews EE, Kenkel AM (2017) Management of sleep-wake disturbances comorbid with cancer. Oncology (Williston Park) 31(8):610–617

17.

Alfano CM, Lichstein KL, Vander Wal GS, Smith AW, Reeve BB, McTiernan A, Bernstein L, Baumgartner KB, Ballard-Barbash R (2011) Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life. Breast Cancer Res Treat 130(1):243–254. https://doi.org/10.1007/s10549-011-1530-2CrossRefPubMedPubMedCentral

18.

Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW (2011) Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol 29(26):3517–3522. https://doi.org/10.1200/JCO.2011.36.1154CrossRefPubMedPubMedCentral

19.

Miaskowski C, Paul SM, Cooper BA, Lee K, Dodd M, West C, Aouizerat BE, Dunn L, Swift PS, Wara W (2011) Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy. Sleep 34(2):171–179. https://doi.org/10.1093/sleep/34.2.171CrossRefPubMedPubMedCentral

20.

Chow S, Wan BA, Pidduck W, Zhang L, DeAngelis C, Chan S, Yee C, Drost L, Leung E, Sousa P, Lewis D, Lam H, Chow R, Lock M, Chow E (2019) Symptom clusters in patients with breast cancer receiving radiation therapy. Eur J Oncol Nurs 42:14–20. https://doi.org/10.1016/j.ejon.2019.07.004CrossRefPubMed

21.

Desai K, Mao JJ, Su I, Demichele A, Li Q, Xie SX, Gehrman PR (2013) Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. Support Care Cancer 21(1):43–51. https://doi.org/10.1007/s00520-012-1490-zCrossRefPubMed

22.

Bischel LE, Ritchie C, Kober KM, Paul SM, Cooper BA, Chen LM, Levine JD, Hammer M, Wright F, Miaskowski C (2016). Age differences in fatigue, decrements in energy, and sleep disturbance in oncology patients receiving chemotherapy. Eur J Oncol Nurs 115-23. https://doi.org/10.1016/j.ejon.2016.07.002

23.

Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, Schwartz K, Katz SJ (2007) Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt) 16(9):1348–1361. https://doi.org/10.1089/jwh.2006.0255CrossRef

24.

Van Onselen C, Cooper BA, Lee K, Dunn L, Aouizerat BE, West C, Dodd M, Paul S, Miaskowski C (2012) Identification of distinct subgroups of breast cancer patients based on self-reported changes in sleep disturbance. Support Care Cancer 20(10):2611–2619. https://doi.org/10.1007/s00520-012-1381-3CrossRefPubMed

25.

Beverly CM, Naughton MJ, Pennell ML, Foraker RE, Young G, Hale L, Feliciano EMC, Pan K, Crane TE, Danhauer SC, Paskett ED (2018) Change in longitudinal trends in sleep quality and duration following breast cancer diagnosis: results from the Women’s Health Initiative. NPJ Breast Cancer 4:15. https://doi.org/10.1038/s41523-018-0065-7CrossRefPubMedPubMedCentral

26.

Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S, Cook K, Devellis R, DeWalt D, Fries JF, Gershon R, Hahn EA, Lai JS, Pilkonis P, Revicki D, Rose M, Weinfurt K, Hays R; PROMIS Cooperative Group (2010) The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol 63(11):1179–1194. https://doi.org/10.1016/j.jclinepi.2010.04.011CrossRef

27.

Cella D, Choi SW, Condon DM, Schalet B, Hays RD, Rothrock NE, Yount S, Cook KF, Gershon RC, Amtmann D, DeWalt DA, Pilkonis PA, Stone AA, Weinfurt K, Reeve BB (2019) PROMIS® adult health profiles: efficient short-form measures of seven health domains. Value Health 22(5):537–544. https://doi.org/10.1016/j.jval.2019.02.004CrossRefPubMedPubMedCentral

28.

Siefert ML, Hong F, Valcarce B, Berry DL (2014) Patient and clinician communication of self-reported insomnia during ambulatory cancer care clinic visits. Cancer Nurs 37(2):E51–E59. https://doi.org/10.1097/NCC.0b013e318283a7bcCrossRefPubMedPubMedCentral

29.

Gallicchio L, MacDonald R, Wood B, Rushovich E, Helzlsouer KJ (2012) Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy. Climacteric 15(4):339–349. https://doi.org/10.3109/13697137.2011.620658CrossRefPubMed

30.

Kwekkeboom KL, Tostrud L, Costanzo E, Coe CL, Serlin RC, Ward SE, Zhang Y (2018) The role of inflammation in the pain, fatigue, and sleep disturbance symptom cluster in advanced cancer. J Pain Sympt Manag 55(5):1286–1295. https://doi.org/10.1016/j.jpainsymman.2018.01.008CrossRef

31.

Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S (2012) Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain, behavior, and immunity 26(5):706–713. https://doi.org/10.1016/j.bbi.2012.02.001CrossRefPubMedPubMedCentral

32.

Sprod LK, Palesh OG, Janelsins MC, Peppone LJ, Heckler CE, Adams MJ, Morrow GR, Mustian KM (2010) Exercise, sleep quality, and mediators of sleep in breast and prostate cancer patients receiving radiation therapy. Commun Oncol 7(10):463–471. https://doi.org/10.1016/s1548-5315(11)70427-2CrossRef

33.

Atrooz F, Salim S (2020) Sleep deprivation, oxidative stress and inflammation. Adv Protein Chem Struct Biol 119:309–336. https://doi.org/10.1016/bs.apcsb.2019.03.001CrossRefPubMed

34.

Wu I, Tsai W, McNeill LH, Lu Q (2020) The associations of self-stigma, social constraints, and sleep among Chinese American breast cancer survivors. Support Care Cancer 28(8):3935–3944. https://doi.org/10.1007/s00520-019-05233-xCrossRefPubMed

35.

Martin CM, Greene D, Harrell JP, Mwendwa DT, Williams CD, Horton S, Cradle M, Hudson BD, Taylor TR (2020) The impact of social constraints on insomnia among African-American breast cancer survivors: the mediating role of fear of recurrence. Psychooncology 29(8):1296–1302. https://doi.org/10.1002/pon.5435CrossRefPubMedPubMedCentral

36.

Jain S, Boyd C, Fiorentino L, Khorsan R, Crawford C (2015) Are there efficacious treatments for treating the fatigue-sleep disturbance-depression symptom cluster in breast cancer patients? A Rapid Evidence Assessment of the Literature (REAL(©)). Breast Cancer (Dove Med Press) 7:267–291. https://doi.org/10.2147/BCTT.S25014CrossRef

37.

Zeichner SB, Zeichner RL, Gogineni K, Shatil S, Ioachimescu O (2017) Cognitive behavioral therapy for insomnia, mindfulness, and yoga in patients with breast cancer with sleep disturbance: a literature review. Breast Cancer (Auckl) 11:1178223417745564. https://doi.org/10.1177/1178223417745564CrossRef

38.

Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, Johnson JA, Mumber M, Seely D, Zick SM, Boyce LM, Tripathy D (2017) Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin 67(3):194–232. https://doi.org/10.3322/caac.21397CrossRefPubMedPubMedCentral

39.

Enderlin CA, Coleman EA, Cole C, Richards KC, Kennedy RL, Goodwin JA, Hutchins LF, Mack K (2011) Subjective sleep quality, objective sleep characteristics, insomnia symptom severity, and daytime sleepiness in women aged 50 and older with nonmetastatic breast cancer. Oncol Nurs Forum 38(4):E314–E325. https://doi.org/10.1188/11.ONF.E314-E325CrossRefPubMed

40.

Kreutz C, Müller J, Schmidt ME, Steindorf K (2021) Comparison of subjectively and objectively assessed sleep problems in breast cancer patients starting neoadjuvant chemotherapy. Support Care Cancer 29(2):1015–1023. https://doi.org/10.1007/s00520-020-05580-0CrossRefPubMed

41.

Reinsel RA, Starr TD, O’Sullivan B, Passik SD, Kavey NB (2015) Polysomnographic study of sleep in survivors of breast cancer. J Clin Sleep Med 11(12):1361–1370. https://doi.org/10.5664/jcsm.5264CrossRefPubMedPubMedCentral

42.

Fox RS, Ancoli-Israel S, Roesch SC, Merz EL, Mills SD, Wells KJ, Sadler GR, Malcarne VL (2020) Sleep disturbance and cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy. Support Care Cancer 28(2):845–855. https://doi.org/10.1007/s00520-019-04834-wCrossRefPubMed

Titel: Factors associated with sleep disturbances in women undergoing treatment for early-stage breast cancer
verfasst von: Susan Grayson
Susan Sereika
Caroline Harpel
Emilia Diego
Jennifer G. Steiman
Priscilla F. McAuliffe
Susan Wesmiller
Publikationsdatum: 10.07.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 1/2022
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-021-06373-9

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Factors associated with sleep disturbances in women undergoing treatment for early-stage breast cancer